By Sarah Collins | Market Realist – Fri, Apr 8, 2016 19:01 BST   Zimmer Biomet Holdings (ZBH) generates approximately 63% of its revenue from its reconstructive business segment. The segment consists of its leading portfolio of knee and hip implants and ~20% of its revenues from the SET (Surgical, Sports Medicine, Extremities, and Trauma) segment. The rest […]